Publications by authors named "A Faro"

Even as many outcomes for people living with cystic fibrosis (PLwCF) improve, individuals still experience extensive symptom burdens. From birth, many PLwCF experience both pain as a symptom of their CF disease and procedural pain, posing detriments to health, functioning, and quality of life. Despite its prevalence and impact, there is no CF-specific guidance for the assessment and management of pain.

View Article and Find Full Text PDF

Objectives: Individuals with congenital isolated growth hormone deficiency (IGHD) in Northeastern Brazil have a normal lifespan with a prolonged healthspan. We hypothesize that their increased healthspan is accompanied by a reduced cognitive decline during aging. We have recently shown that these individuals have a similar total cognitive function and better attention and executive function than controls.

View Article and Find Full Text PDF

Background: The Cystic Fibrosis Foundation Patient Registry (CFFPR) maintains clinical data, including history of solid organ transplant, on people with cystic fibrosis (CF) who obtain care at CF Foundation-accredited care centers. The Scientific Registry of Transplant Recipients (SRTR) database is a collection of national data related to organ transplantation that supports research to evaluate solid organ transplant candidate and recipient outcomes.

Methods: Individuals in the CFFPR were matched to SRTR records using an algorithm that compared names, last four digits of social security numbers, date of birth and date of death.

View Article and Find Full Text PDF
Article Synopsis
  • In 2015, a survey indicated gaps in cystic fibrosis (CF) physicians' knowledge about lung transplant (LTx) referrals, prompting the creation of new referral guidelines and the introduction of elexacaftor/tezacaftor/ivacaftor (ETI) treatment for many patients.
  • A survey of CF center directors revealed that while many physicians recognize key indicators for LTx, a significant number still delay referrals for patients who qualify based on their lung function.
  • Despite improvements in understanding transplant criteria, many physicians express uncertainty about the best timing for referrals, especially for patients on ETI, indicating a need for updated guidelines as more data on ETI's long-term effects are available.
View Article and Find Full Text PDF

Arteriogenesis is an inflammatory driven mechanism, describing the growth of a natural bypass from pre-existing collateral arteries to compensate for an occluded artery. The complement system component C3 is a potent natural inflammatory activator. Here, we investigated its impact on the process of collateral artery growth using C3-deficient (C3 -/-) and wildtype control mice in a murine hindlimb model of arteriogenesis.

View Article and Find Full Text PDF